An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells.

An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells.
复制标题

DOI:
10.1016/j.canlet.2013.06.026
复制
发表时间:
2013-10-28
期刊:
影响因子:
9.7
通讯作者:
Zheng, Jing
Zheng, Jing
中科院分区:
医学1区
文献类型:
--
作者:
Wang, Kai;Li, Yan;Jiang, Yi-Zhou;Dai, Cai-Feng;Patankar, Manish S.;Song, Jia-Sheng;Zheng, Jing

文献摘要

参考文献

被引文献

相似文献

芳香烃受体(aryl hydrocarbon receptor,AhR)是一种配体激活的转录因子,参与多种生物学过程。本文研究了内源性AhR配体2-(1′ H-吲哚-3 ′-羰基)-噻唑-4-羧酸甲酯(ITE)是否通过AhR调控人卵巢癌细胞的增殖和迁移。我们发现AhR广泛存在于许多组织型卵巢癌组织中。ITE在体外抑制OVCAR-3细胞增殖和SKOV-3细胞迁移,这被AhR敲低阻断。ITE还抑制小鼠中OVCAR-3细胞的生长。这些数据表明,ITE可能有可能用于至少一部分人类卵巢癌的治疗干预。
The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor mediates many biological processes. Herein, we investigated if 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE, an endogenous AhR ligand) regulated proliferation and migration of human ovarian cancer cells via AhR. We found that AhR was widely present in many histotypes of ovarian cancer tissues. ITE suppressed OVCAR-3 cell proliferation and SKOV-3 cell migration in vitro, which were blocked by AhR knockdown. ITE also suppressed OVCAR-3 cell growth in mice. These data suggest that the ITE might potentially be used for therapeutic intervention for at least a subset of human ovarian cancer.
芳基烃受体在女性生殖系统中的作用。
DOI: 10.1016/j.bcp.2008.09.037
发表时间: 2009-02-15
影响因子: 5.8
作者:
Hernandez-Ochoa, Isabel;Karman, Bethany N.;Flaws, Jodi A.
通讯作者: Flaws, Jodi A.
DOI: 10.1038/nrc2644
发表时间: 2009-06
期刊: Nature reviews. Cancer
影响因子: --
作者:
通讯作者: --
DOI: 10.1016/j.ejphar.2005.11.023
发表时间: 2006-01-13
影响因子: 5
作者:
Juan, SH;Lee, JL;Lee, WS
通讯作者: Lee, WS
DOI: 10.1073/pnas.232562899
发表时间: 2002-11-12
影响因子: 11.1
作者:
Song, JS;Clagett-Dame, M;DeLuca, HF
通讯作者: DeLuca, HF
DOI: 10.1093/aje/kwm371
发表时间: 2008-04-01
影响因子: 5
作者:
Consonni, Dario;Pesatori, Angela C.;Bertazzi, Pier Alberto
通讯作者: Bertazzi, Pier Alberto